MYIA
CNMD icon

Mount Yale Investment Advisors’s CONMED CNMD Stock Holding History

Mount Yale Investment Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-266
Closed -$18K – 406
2018
Q3 		$18K Buy
+266
New +$20.6K ﹤0.01% 800

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mount Yale Investment Advisors's CNMD Position: Q4 2018 in Review

Mount Yale Investment Advisors sold out of CONMED (CNMD) in Q4 2018, closing a stake of 266 shares — an estimated $18K sold.

Mount Yale Investment Advisors first reported a position in CNMD in Q3 2018 and held it in 1 quarter. The position peaked at $18K in Q3 2018. 207 funds tracked by Wall St. Rank hold CNMD as of Q4 2018.

  • Mount Yale Investment Advisors reported no remaining CONMED position as of Q4 2018 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 266 CONMED shares in Q4 2018, an estimated $18K.
  • Mount Yale Investment Advisors first reported a position in CONMED in Q3 2018 and held it in 1 quarter.
  • Mount Yale Investment Advisors's CONMED position peaked at $18K in Q3 2018.
  • 207 funds tracked by Wall St. Rank held CONMED as of Q4 2018.

Based on Mount Yale Investment Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.